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Abstract
We encountered two cases of endometrioid carcinoma of uterus with extensive surface epithelial changes (SECs)
mimicking serous borderline tumor (SBT) of the ovary. The first case was a well-differentiated endometrioid
carcinoma arising in a background of complex atypical hyperplasia. The second case was moderately-differentiated
endometrioid carcinoma with squamous and mucinous differentiation. The SECs comprised of thin microapapillae
without hierarchal branching, lined by cuboidal cells with eosinophilic cytoplasm and mild to moderate nuclear
atypia. These areas were reminiscent of SBTs of ovary, micropapillary type. This report expands the existing
spectrum of SECs. Serous borderline tumor of ovary like surface epithelial changes could be misleading if present
in an endometrial biopsy or curettings. Therefore, knowledge of this morphologic variation is important.
Introduction
The surface epithelial changes (SECs), typically seen in
well to moderately differentiated endometrioid carci-
noma of endometrium, are histologically defined by bet-
t e rc e l l u l a rd i f f e r e n t i a t i o nand an architectural pattern
different from underlying carcinoma. The SECs can
occur as microglandular, solid syncytial or as mixture of
both patterns [1]. The microglandular pattern is charac-
terized by small, tightly packed round glands, lined by
cuboidal to columnar cells containing abundant eosino-
philic cytoplasm with round to oval nuclei, mimicking
microglandular endocervical hyperplasia. The solid syn-
cytial type pattern shows syncytial aggregates of cells
with eosinophilic cytoplasm showing micropapillary,
squamoid or transitional-type differentiation. The better
cellular differentiation manifests as low nuclear cytoplas-
mic ratio, absent or rare nucleoli and no mitosis.
The papillary syncytial metaplastic pattern is similar to
papillary syncytial change seen with endometrial break-
down. We encountered two cases of endometrioid
carcinoma showing exuberant SECs, histologically
mimicking serous borderline tumor (SBT) of ovary. This
is unusual and has not been described in literature.
We discuss both cases and review associated literature
of SEC.
Case report 1
A 56 year-old female underwent total hysterectomy with
bilateral salpingo-oophorectomy for uterine endometrioid
carcinoma. The macroscopic examination showed a 9.0 ×
5.0 × 3.0 cm polypoidal tumor involving uterine corpus
and cervix invading more than 50% of myometrium. The
microscopic examination showed FIGO Grade 2/3 endo-
metrioid carcinoma with squamous and mucinous differ-
entiation. The tumor showed exuberant SECs comprising
of cuboidal tumor cells with well-defined cytoplasmic bor-
ders, moderate eosinophilic cytoplasm and round to oval
nuclei with inconspicuous nucleolus. These cells were
arranged in papillary pattern (Figure 1A) and classic well
differentiated endometrioid adenocarcinoma (Figure 1B).
This peculiar pattern was reminiscent of serous borderline
tumor of ovary with “Medusa head-like appearance”
(Figure 1C). Figure 1D shows multilayered cuboidal cells
with “cracked” appearance. Figure 1E reveals PTEN-null
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any medium, provided the original work is properly cited.Figure 1 Case 1 (A - H). Scanning power (A) showing well differentiated endometrioid carcinoma with SECs mimicking micropapillary serous
borderline tumor of the ovary. Medium power (B) showing area of well differentiated endometrioid carcinoma, (C) with “Medusa head-like
appearance”, (D) multilayered cuboidal cells with “cracked” appearance. (E) PTEN-null (F) focal faint p53 immunostaining in SECs and (G, H)
typical “cracked” artifact in micropapillary serous borderline tumors, low and high magnifications respectively of Case 2.
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ing in SECs.
T h eu t e r i n ec e r v i xw a si n v o l v e db yt u m o ra n dl y m -
phatic invasion was also identified microscopically.
Case report 2
A 65-year-old postmenopausal female presented with
chief complaint of vaginal bleeding. She underwent exci-
sion of a cervical polyp. The microscopic examination
showed a well differentiated endometrioid carcinoma
arising in a background of complex atypical hyperplasia
of endometrium. The tumor also showed exuberant
SECs, which consisted of multiple micro papillae with
non-hierarchal branching, lined by cuboidal cells with
well-defined cytoplasmic membrane, moderate eosino-
philic cytoplasm, round to oval nucleus with inconspicu-
ous nucleolus, reminiscent of micropapillary SBT of the
ovary. Figures 1G and 1H show typical “cracked” artifact
seen in serous borderline tumor of ovary, low and high
magnifications respectively. These cells showed focal
cytoplasmic clearing and glandular lumen formation.
There was no evidence of high grade serous carcinoma.
Discussion
In 1980, Kempson et al coined the term “endometrial
epithelial metaplasias” for the phenomenon of replace-
ment of the surface endometrial glandular epithelium
with an epithelium that is normally encountered in
another mullerian-derived organ such a fallopian tube or
endocervix. The authors described total seven patterns of
metaplasia including already well known squamous meta-
plasia and adding six other types including papillary,
tubal, eosinophilic, mucinous, hobnail and clear cell type.
Interestingly, all the 89 cases reported by Kempson et al
were benign and none of them showed any evidence of
invasive adenocarcinoma on hysterectomy specimen [2].
In 1987, Anderson et al reported the association of endo-
metrial metaplasia with endometrial adenocarcinoma.
Their 15/40 cases with endometrial carcinoma had asso-
ciated endometrial metaplasia. The eosinophilic metapla-
sia was the most common metaplasia associated with
endometrial cancer. An important observation made was
that carcinoma occurring with metaplasia was always
low-grade, occurred in young females with associated
hyperplasia and hyperestrogenism [3]. A similar associa-
tion between endometrial metaplasias and endometrial
carcinoma was reported by Kaku T et al [4].
The metaplastic changes have been described in both
benign and malignant endometrial processes. Jacques
SM et al segregated the metaplastic changes in carcino-
mas from the benign endometrium. Jacques SM et al
called the metaplastic changes occurring on the surface
of the endometrial adenocarcinoma as “surface epithelial
changes”. They described two distinct types of patterns:
papillary syncitial type and microglandular type. Most
commonly, endometrial adenocarcinoma showed admix-
ture of these two patterns, however these patterns are
also present exclusively on the tumor surface. The SEC
showed less atypicality than the underlying carcinoma.
However, the nuclear atypia in the SEC is more than
the benign endometrial metaplasia. The papillary synci-
tial type of SEC resembles the papillary syncitial change
seen with endometrial breakdown. The microglandular
type of SEC mimics the microglandular hyperplasia of
the cervix [1].
The SECs mimicking the serous borderline tumor of
ovary have not been reported in the literature. These
SECs differ from the two types of SECs described by
Jacques SM et al. In our cases, cells only focally formed
glandular lumen and the cells were less atypical than
the underlying tumor cells. Most of the metaplastic
change comprised of thin cords of the eosinophilic
cuboidal cells with distinct cell membrane arranged in
micropapillae with non-hierarchal branching. In a study
of 399 consecutive cases of endometrioid carcinoma,
Murray SK et al identified 26 cases of uterine endome-
trioid carcinoma with small nonvillous papillae (ECSP).
In their study, they compared ECSP with uterine serous
carcinoma, and therefore did not use the term “micro-
papillary”, to avoid confusion with micropapillary type
of serous carcinoma. Murray et al concluded that endo-
metrioid carcinoma with small nonvillous papillae may
be confused with serous papillary carcinoma on micro-
scopic examination [5].
On one hand the molecular changes in two major sub-
types of endometrial cancer are well known: the estro-
gen-related type I shows defects in DNA-mismatch
repair, mutations in PTEN, beta-catenin, and k-ras, while
type II, nonendometrioid such as papillary serous and
clear cell shows aneuploidy and p53 mutations [6]. The
mechanism of origin of the SEC is unclear. Jacques SM
proposed that SECs occur only under the condition of a
larger space into which the epithelium can proliferate.
Thus, SEC develops only on the endometrial surface and
in the dilated malignant glands involving adenomyosis.
There is a strong association of endometrial metaplasia
with exogenous estrogen intake [4]. Very few studies
have investigated the molecular characteristics of the
SECs. Quddus et al observed weak and heterogenous p53
reactivity in the metaplastic endometrium [7]. Interest-
ingly, p53 staining is absent in normal and hyperplastic
endometrium while a strong, diffuse p53 staining is diag-
nostic of uterine papillary serous carcinoma. Quddus
et al reported variable PTEN expression in the surface
epithelial changes associated with hyperplasia and endo-
metrioid carcinoma [8].
To our knowledge, SECs mimicking serous borderline
tumor of the ovary have not been described in English
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SECs described with the endometrioid carcinoma. One
of the cases showed PTEN null phenotype and weak,
focal p53 expression by immunohistochemistry, support-
ing the idea that these SECs originated from the under-
lying endometrioid carcinoma rather than a denovo
phenomenon. Knowledge of this morphological variation
in SECs may be important while interpreting the endo-
metrial biopsy/curettage for an endometrial cancer.
Consent
The Institutional Review Board of our academic institu-
tion does not require approval for case reports as long
as no patient personal identification information or
patient photograph are included. Our report does not
include any personal identification of the patient or
patient photograph.
Author details
1Department of Pathology, Rhode Island Hospital, 593 Eddy Street, APC 12,
Providence, RI, 02903, USA.
2Department of Pathology, Women & Infants
Hospital of Rhode Island. The Alpert Medical School of Brown University, 101
Dudley St, Providence, RI 02905, USA.
Authors’ contributions
KS prepared the manuscript and the figures. RAS helped in preparing the
final manuscript and did PTEN staining. CZ contributed one of the cases.
MRQ contributed one case, initiated the case report and coordinated the
preparation of the manuscript. All authors read and approved the final
manuscript.
Competing interests
The authors declare that they have no competing interests.
Received: 6 May 2010 Accepted: 27 January 2011
Published: 27 January 2011
References
1. Jacques SM, Qureshi F, Lawrence WD: Surface epithelial changes in
endometrial adenocarcinoma: diagnostic pitfalls in curettage specimens.
Int J Gynecol Pathol 1995, 14(3):191-7.
2. Hendrickson MR, Kempson RL: Endometrial epithelial metaplasias:
proliferations frequently misdiagnosed as adenocarcinoma. Report of 89
cases and proposed classification. Am J Surg Pathol 1980, 4(6):525-42.
3. Andersen WA, et al: Endometrial metaplasia associated with endometrial
adenocarcinoma. Am J Obstet Gynecol 1987, 157(3):597-604.
4. Kaku T, et al: Association of endometrial epithelial metaplasias with
endometrial carcinoma and hyperplasia in Japanese and American
women. Int J Gynecol Pathol 1993, 12(4):297-300.
5. Murray SK, Young RH, Scully RE: Uterine Endometrioid Carcinoma with
Small Nonvillous Papillae: An Analysis of 26 Cases of a Favorable-
Prognosis Tumor To Be Distinguished from Serous Carcinoma. Int J Surg
Pathol 2000, 8(4):279-289.
6. Hecht JL, Mutter GL: Molecular and pathologic aspects of endometrial
carcinogenesis. J Clin Oncol 2006, 24(29):4783-91.
7. Quddus MR, et al: p53 immunoreactivity in endometrial metaplasia with
dysfunctional uterine bleeding. Histopathology 1999, 35(1):44-9.
8. Quddus MR, et al: Utility of PTEN expression of endometrial “surface
epithelial changes” and underlying atypical endometrial hyperplasia. Int
J Gynecol Pathol 2009, 28(5):471-6.
doi:10.1186/1746-1596-6-13
Cite this article as: Singh et al.: “Surface epithelial changes” in uterine
endometrioid carcinoma mimicking micropapillary serous borderline
tumor of ovary: report of two cases and review of the literature.
Diagnostic Pathology 2011 6:13.
Submit your next manuscript to BioMed Central
and take full advantage of: 
• Convenient online submission
• Thorough peer review
• No space constraints or color ﬁgure charges
• Immediate publication on acceptance
• Inclusion in PubMed, CAS, Scopus and Google Scholar
• Research which is freely available for redistribution
Submit your manuscript at 
www.biomedcentral.com/submit
Singh et al. Diagnostic Pathology 2011, 6:13
http://www.diagnosticpathology.org/content/6/1/13
Page 4 of 4